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Abstract 
Purpose: To examine the relationship between higher antioxidant activity and aggregation or 
disaggregation of beta-amyloid (Aβ) for 21 plants. 
Methods: Twenty-nine natural plant extracts and their antioxidant activities were analyzed using DPPH 
assay. The aggregation and disaggregation of Aβ were analyzed using Thioflavin-T assay.  
Results: Eleven plant extracts exhibited high antioxidant activities with the half-maximal inhibitory 
concentration (IC50) values < 20.0 μg/mL. Furthermore, the plant extracts efficiently inhibited Aβ 
aggregation with a mean IC50 value of 17.0 μg/mL. However, four plant extracts exhibiting low 
antioxidant activities (IC50 > 80.0 μg/mL) inhibited Aβ aggregation less efficiently with a mean IC50 value 
of 75.7 μg/mL. Furthermore, plant extracts with high antioxidant activities were not invariably efficient for 
disaggregating pre-formed Aβ aggregates. 
Conclusion: High antioxidant activities were positively correlated with the inhibition of Aβ aggregation, 
although not with the disaggregation of pre-formed Aβ aggregates. Nevertheless, potent antioxidants 
may be helpful in treating Alzheimer’s disease.  
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β-amyloid (Aβ) is a polypeptide of 36-43 amino 
acids, and is a major causative factor of 
Alzheimer’s disease (AD). Aβ aggregation into 
senile plaques is a pathological characteristic 
detected in the brains of patients with AD. Aβ is 
produced by the sequential cleavage of amyloid 
precursor proteins by β- and γ-secretases. Aβ 
molecules undergo self-aggregation to form 
oligomers and fibrils, which cause neurotoxicity 
via oxidative stress, disturb calcium homeostasis, 
and induce mitochondrial dysfunction, and neuro-
inflammation. Thus, the discovery of compounds 
or extracts that inhibit Aβ aggregation, and 
induce the disaggregation of Aβ aggregates 
could be an effective approach to the therapy 
and prevention of AD. 
 
Antioxidants are molecules that scavenge free 
radicals and reactive oxygen species (ROS), 
which can induce oxidative stress, and 
consequently, cellular damages. Antioxidant 
intake is helpful in preventing human diseases 
[1]. For example, antioxidants can reduce the risk 
of cardiovascular diseases by inhibiting vascular 
inflammation, lipid peroxidation, and platelet 
aggregation [2]. Additionally, antioxidants are 
known to have anti-cancer, anti-diabetic, and 
anti-aging effects [3-5]. Antioxidants are also 
considered helpful in treating AD, because the 
ROS generated in AD pathology causes 
neuronal damage [6]. Furthermore, certain 
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antioxidants such as polyphenols inhibit Aβ 
aggregation, and destabilize preformed Aβ 
aggregates [7,8]. However, the relationships 
between antioxidant activity and inhibition of Aβ 
aggregation, and between antioxidant activity 
and disaggregation of preformed Aβ aggregates 
are not analyzed. Therefore, in this study, 29 
natural plant extracts with diverse antioxidant 
activity were analyzed for effects on the 
aggregation and disaggregation of Aβ, and the 




Materials and reagents 
 
Thioflavin T (ThT), DPPH, and dimethyl sulfoxide 
(DMSO) were purchased from Sigma-Aldrich 
(MO, USA). Ethanol and methanol were 
purchased from Samchun (Pyeong-Taek, Korea). 





Twenty-nine plant materials (Table 1) were 
purchased from a commercial market (Samhing 
medicinal herb market; Seoul, Korea) in 2014. 
One of the authors (S-Y Park) performed 
botanical identification and voucher specimens 
were deposited in Pharmacognosy laboratory of 
College of Pharmacy, Dankook University. 
 
Preparation of plant extracts 
 
Dried and pulverized plant materials were 
extracted 3 times with 90 % methanol at room 
temperature. The MeOH filtrate was evaporated 
under vacuum to yield the MeOH extract. Each 
extract was dissolved in DMSO and stored at -20 




The antioxidant activities of the plant extracts 
were determined using a stable free radical, 
DPPH. The ability of the plant extracts to 
scavenge DPPH, and convert it to 1,1-diphenyl-
2-picrylhydrazine was determined 
colorimetrically. In brief, the plant extracts at 
different concentrations of (4, 20, and 100 
μg/mL) were mixed with 190 μL of DPPH (0.316 
mM in ethanol) and the mixtures were incubated 
at 37 °C for 30 min. The optical density values of 
the mixtures were measured at 517 nm with a 
microplate reader (Molecular Devices, 
Sunnyvale, CA, USA). All measurements were 
conducted out at least thrice. 
 
 
ThT assay of inhibition of Aβ aggregation 
 
To quantify Aβ aggregates, the ThT assay was 
performed. Aβ1-42 was dissolved in DMSO at 1 
mL, and stored at -20 °C until use. To monitor 
their effects on Aβ aggregation, the plant extracts 
(4, 20, and 100 µg/mL) were incubated with 20 
µM of Aβ (49 µL) at 37 °C for 24 h. Then, 3 µM of 
ThT (50 µL) was added, and the fluorescence 
was measured after 30 min with an EMax 
precision microplate reader (Molecular Devices) 
with excitation at 442 nm and emission at 485 
nm. Aβ treated with DMSO was used as the 
control, and each assay was performed in 
triplicate. 
 
ThT assay of disaggregation of preformed Aβ 
aggregates 
 
To monitor the effects of the plant extracts on the 
disaggregation of the Aβ aggregates, 20 µM of 
Aβ (49 µL) was incubated at 37 °C. After 24 h, 
the plant extracts (4, 20, and 100 µg/mL) were 
added, and incubated for an additional 24 h. 
Subsequently, 3 µM of ThT (50 µL) was added, 
and the fluorescence was measured as 




Data were expressed as means ± SD. Two or 
more group comparisons were performed by 
one-way analysis of variance (ANOVA), followed 
by Tukey’s post-hoc test (SPSS version 17.0; 
IBM SPSS, Armonk, NY, USA). Differences were 




Antioxidant effects of the plant extracts 
 
The results of DPPH assay showed that 
Agrimonia pilosa, Cornus officinalis, Rubus 
coreanus, Sophora japonica, and Paeonia 
suffruticosa exhibited strong antioxidant effects 
with IC50 values below than 10 μg/mL. 
Contrastingly, Houttuynia cordata, Torilis 
japonica, Rehmannia glutinosa, and Arisaema 
erubescens exhibited relatively poor antioxidant 
activities with IC50 values higher than 100 μg/mL 
(Table 1). 
 
Inhibition of Aβ aggregation by the plant 
extracts 
 
The ThT assay demonstrated that Cornus 
officinalis exhibited the highest inhibitory effect 
on Aβ aggregation with an IC50 value of 8.2 
μg/mL (Table 1). 
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Table 1: List of some plant species, and their antioxidant, anti-amyloidogenic and Aβ disaggregating activities 
 
Plant  Plant part used  
Antioxidant 
effect 










Agrimonia pilosa Ledebour 
(Rosaceae) 
Whole plant 5.1 9.1 102.3 
Amomum villosum Loureiro 
(Zingiberaceae) 
Fruit/Seed 17 13.8 39.9 
Arisaema erubescens Schott 
(Araceae) 
Root 90.9 98.3 114.2 
Chelidonium majus Linn&eacute; 
var. asiaticum Ohwi (Papaveraceae) 
Aerial parts 78.2 72.4 104.2 
Chrysanthemum zawadskii Herbich 
var. latilobum (Maxim.) Kitamura 
(Compositae) 
Whole plant 27.8 46.4 179.7 
Cimicifuga heracleifolia Komarov 
(Ranunculaceae) 
Rhizome 52.7 76.1 115.7 
Cornus officinalis Siebold et 
Zuccarini (Cornaceae) 
Fruit 5.3 8.2 42.1 
Cyperus rotundus L (Cyperaceae) Rhizome 26 15.2 42.9 
Drynaria fortunei J. Smith 
(Polypodiaceae)  
Rhizome 19.7 16.1 134.9 
Epimedium koreanum Nakai 
(Berberidaceae) 
Aerial parts 46.8 39.4 110.6 
Eucommia ulmoides Oliver 
(Eucommiaceae) 
Leaves 72.5 56.1 234.1 
Houttuynia cordata Thunberg 
(Saururaceae) 
Aerial parts 134.4 99.3 276.4 
Hovenia dulcis Thunb 
(Rhamnaceae) 
Fruit/Seed 31.4 46.6 124.6 
Leonurus japonicus Houttuyn 
(Labiatae) 
Aerial parts 64.1 47.9 25.7 
Magnolia obovata Thunberg 
(Magnoliaceae) 
Bark 30 49.3 130.3 
Morus alba Linne (Moraceae) Leaves 74.2 44.5 73.8 
Myristica fragrans Houttuyu 
(Myristicaceae) 
Seed 59 51.3 88.4 
Paeonia lactiflora Pall 
(Ranuculaceae) 
Root 10 24.4 48.2 
Paeonia suffruticosa Andrews 
(Paeoniaceae) 
Root bark 7.8 20.8 92.9 
plantago asiatica L (Plantaginacea) Seed 12.8 20.6 127.7 
Prunella vulgaris L (Labiatae) Stem 14.6 24.8 45 
Rehmannia glutinosa Liboschitz ex 
Steudel (Scrophulariaceae) 
Root 109.5 80.2 396.9 
Rubus coreanus Miquel (Rosaceae) Fruit 6 12.8 146.1 
Schizonepeta tenuifolia Briquet 
(Labiatae) 
Flower 29.8 32.1 57.7 
Scrophularia buergeriana Miquel 
(Scrophulariaceae) 
Root 53.8 72.8 67.4 
Sophora japonica L (Leguminosae) Flower 7.1 25.2 134.3 
Thuja orientalis L (Curpressaceae) Leaves 16.7 10.8 14.7 
Torilis japonica Decandolle 
(Umbelliferae) 
Fruit 100.9 87.5 377.6 
Zingiber officinale Roscoe 
(Zingiberaceae) 
Rhizome 65.7 47.2 137.4 
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Aβ incubation with 100 μg/mL C. officinalis 
reduced the extent of Aβ aggregation to 23 %, 
compared with the DMSO-treated control groups 
(Figure 1A). Similarly, Thuja orientalis and 
Agrimonia pilosa had strong inhibitory effects on 
Aβ aggregation with IC50 values of 9.1 and 10.8 
μg/mL (Table 1), respectively. T. orientalis and A. 
pilosa at 100 μg/mL reduced Aβ aggregation to 
16.5 % and 26.2 %, respectively, compared with 
the DMSO-treated control groups (Figure 1A). 
However, Torilis japonica, Arisaema erubescens, 
and Houttuynia cordata were less efficient in 
inhibiting Aβ aggregation, and their IC50 values 
were 87.5, 98.3 and 99.3, respectively (Table 1). 
Incubation with 100 μg/mL T. japonica, A. 
erubescens, and H. cordata reduced Aβ 
aggregation to 47.2 %, 49.9 %, and 43.6 %., 
whereas these plant extracts at 4 μg/mL 
exhibited negligible inhibitory effects on Aβ 
aggregation (Figure 1B). 
 
Effects of the plant extracts on disaggrega-
tion of Aβ aggregates 
 
The disaggregating effects of the 29 plant 
extracts on pre-aggregated Aβ aggregates were 
determined by the ThT assay. Thuja orientalis 
exhibited the highest disaggregating activity 
among the 29 plant extracts with an IC50 value of 
14.7 μg/mL (Table 1). Similarly, Leonurus 
japonicus efficiently induced the disaggregation 
of preformed Aβ aggregates with an IC50 value of 
25.7 μg/mL. Contrarily, the effects of Torilis 
japonica and Rehmannia glutinosa on the 
disaggregation of preformed Aβ aggregates were 
extremely minimal with IC50 values of 377.6 and 
396.9 μg/mL, respectively. 
 
Antioxidant activity and inhibition of Aβ 
aggregation 
 
To determine the relationship between the 
inhibition of Aβ aggregation and antioxidant 
activity, twenty-nine plants were divided into 4 
groups based on the IC50 values for antioxidant 
activity (group 1, IC50 value: 0–20; group 2, IC50 
value: 21–50; group 3, IC50 value: 51-80, and 
group 4, IC50 value over 81). The average IC50 
values for the antioxidant activities of the groups 
1, 2, 3, and 4 were 11.1, 32.0, 65.0, and 86.1 
μg/mL, respectively (Figure 2A), whereas the 
average IC50 values for anti- Aβ aggregation in 
the groups 1, 2, 3, and 4 were 17.0, 38.2, 58.5 
and 75.7 μg/mL, respectively. The average IC50 
value for anti- Aβ aggregating activities of the 
plant extracts in group 1 was significantly lower 
than those of the groups 2, 3, and 4. These 
results indicated that the plant extracts with 
higher antioxidant activities exhibited higher anti-
Aβ aggregating activities. Therefore, plants with 
higher antioxidant activities could be beneficial 
for patients with AD because of their possibly 
higher anti-Aβ aggregating activities. 
 
Antioxidant activity and disaggregation of Aβ 
aggregates 
 
To determine the relationship between 
antioxidant activity and the disaggregation of Aβ 
aggregates, the mean IC50 values of groups 1-4 
for the disaggregation of Aβ aggregates were 
compared (Figure 2C). The average IC50 values 
of the groups 1, 2, 3, and 4 for Aβ disaggregation 
were 84.3, 107.6, 105.8, and 291.2 μg/mL, 
respectively. Group 1 exhibited a relatively low 
IC50 value for Aβ disaggregation; however, it was 
not significantly different from those of groups 2 
and 3. However, the disaggregating activities of 
groups 1, 2, and 3 were significantly different 




Natural products containing polyphenolic 
compounds, such as berries, spices, and green 
tea, are known to have antioxidant and 
neuroprotective activities. Furthermore, the 
neuroprotective effects of natural polyphenolic 
compounds, such as myricetin and luteolin are 
exerted, at least partially, by attenuating Aβ-
induced toxicity [9]. 
 
Figure 1: Anti-amyloidogenic effects of the plant extracts. (A) Anti- Aβ aggregation effects of the plant extracts, 
such as Cornus officinalis, Thuja orientalis and Agrimonia pilosa, with high antioxidant activity (IC50 < 16.7 
μg/mL). (B) Anti-Aβ aggregation effects of the plant extracts, such as Torilis japonica, Arisaema erubescens, and 
Houttuynia cordata, with low antioxidant activity (IC50 > 90 μg/mL). 
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Figure 2: Mean values of the antioxidant, anti-Aβ aggregating and Aβ-disaggregating activities of 29 plant 
extracts divided into 4 groups based on antioxidant activity. (A) Average values of antioxidant activities, (B) 
average values of anti- Aβ aggregating activities and (C) average values of Aβ-disaggregating activities. a P < 
0.05, different from Group 1, b P < 0.05, different from Group 2, c P < 0.05, different from Group 3, d P < 0.05, 
different from Group 4 
 
However, this does not indicate that potent 
antioxidants are efficient in the inhibition of Aβ 
aggregation and disaggregation of Aβ 
aggregates. Therefore, in this study, the 
relationships between antioxidant activity and 
inhibition of Aβ aggregation, and between 
antioxidant activity and disaggregation of 
preformed Aβ aggregates were examined. 
 
The aggregation of Aβ monomers to form 
oligomers and fibrils (aggregates) induces 
neurotoxicity. Oxidative stress, induced during 
Aβ aggregation, disrupts synapses, and impairs 
the functions of synapses and membranes 
[10,11]. Thus, antioxidants could be helpful in 
treating AD by reducing oxidative stress-related 
neuronal damage. Additionally, the use of 
compounds or extracts inhibiting Aβ aggregation 
is considered a good approach to the therapy 
and prevention of AD. For example, flavonoids 
such as myricetin, quercetin, and kaempferol 
inhibited Aβ aggregation (exhibited anti-
amyloidogenic activities) [12-14]. Additionally, 
rosmarinic acid and curcumin are other 
compounds that inhibit Aβ aggregation efficiently 
[15,16]. Interestingly, these compounds are 
known to have high antioxidant activities. 
Consistent with previous reports, our results 
suggested that the plant extracts with relatively 
high antioxidant activity inhibited Aβ aggregation 
efficiently. This could be because potent 
antioxidants, such as polyphenols, in the plant 
extracts interact with aromatic regions in Aβ, 
disrupt the self-assembly of Aβ into β-sheet 
conformational stacking, and eventually, inhibit 
Aβ aggregation [17].  
 
Antioxidants are also considered efficient in 
disaggregating Aβ. Curcumin and β-carotene 
exhibited high Aβ-disaggregating activities owing 
to their symmetric rod-like structures and 
hydrophobic moieties that wedged into Aβ cores, 
and disrupt the β-sheet structures [18,19]. 
However, the increases in hydrophilicity reduced 
Aβ-disaggregating activity [18]. Furthermore, 
morin is an efficient Aβ-disaggregating flavonoid. 
The aromatic moiety and hydrogen-bonding 
capacity of morin are suggested to cause the 
disaggregation of Aβ aggregates [20]. These 
reports suggest that molecules with 
hydrophobicity, aromatic moiety, and hydrogen 
bonding-capacity might, at least, partially 
contribute to the disaggregation of Aβ 
aggregates. Consistent with these results, our 
study similarly suggested that antioxidants are 
not invariably positively correlated with high Aβ-
disaggregating activity. Altogether, these results 
suggested that the plant extracts with high 
antioxidant activities are efficient in inhibiting Aβ 
aggregation; however, they were not invariably 
efficient in disaggregating Aβ aggregates. 
Nonetheless, antioxidants could be beneficial for 
patients with AD owing to their possible anti-Aβ 
aggregating and Aβ-disaggregating activities. 
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Twenty-nine plant extracts have been analyzed 
for antioxidant, anti-amyloidogenic, and Aβ 
disaggregating activities. The plant extracts with 
high antioxidant activity inhibit Aβ aggregation 
more efficiently than those with low antioxidant 
activity; however, antioxidant activity correlates 
weakly with the disaggregation of pre-formed Aβ 
aggregates. Nevertheless, good antioxidants 
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